Increasing Coverage in Mass Drug Administration for Lymphatic Filariasis Elimination in an Urban Setting: a Study of Malindi Town, Kenya

被引:39
作者
Njomo, Doris W. [1 ]
Mukoko, Dunstan A. [2 ]
Nyamongo, Nipher K. [1 ]
Karanja, Joan [3 ]
机构
[1] Kenya Med Res Inst KEMRI, Eastern & Southern Africa Ctr Int Parasite Contro, Nairobi, Kenya
[2] Minist Hlth, Div Vector Borne & Neglected Trop Dis, Nairobi, Kenya
[3] Minist Hlth, Malindi Dist Hosp, Malindi, Kenya
基金
比尔及梅琳达.盖茨基金会;
关键词
DIETHYLCARBAMAZINE; PROGRAM; ALBENDAZOLE; IVERMECTIN; INFECTION; INDIA;
D O I
10.1371/journal.pone.0083413
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Implementation of Mass Drug Administration (MDA) in urban settings is an obstacle to Lymphatic Filariasis (LF) elimination. No urban-specific guidelines on MDA in urban areas exist. Malindi district urban area had received 4 MDA rounds by the time the current study was implemented. Programme data showed average treatment coverage of 28.4% (2011 MDA), far below recommended minimum of 65-80%. Methods: To identify, design and test strategies for increased treatment coverage in urban areas, a quasi-experimental study was conducted in Malindi urban area. Three sub-locations with lowest treatment coverage in 2011 MDA were purposively selected. In the pre-test phase, 947 household heads sampled using systematic random method were interviewed for quantitative data. For qualitative data, 12 Focus Group Discussions (FGDs) with single sex adult and youth male and female groups and 3 with community drug distributors (CDDs) were conducted. Forty in-depth interviews with opinion leaders and self-administered questionnaires with District Public Health officers purposively selected were carried out. The quantitative data were analyzed using SPSS version 16 and statistical significance assessed by x(2) test. The qualitative data were analyzed manually according to study's themes. Results and Discussion: The identified strategies were implemented prior to and during 2012 MDA in two sub-locations (experimental) while in the third (control), usual MDA strategies were applied. In the post-test phase, 2012 MDA coverage in experimental and control sub-locations was comparatively assessed for effect of the newly designed strategies on urban MDA. Results indicated improved treatment coverage in experimental sub-locations, 77.1% in Shella and 66.0% in Barani. Central (control) sub-location also attained high coverage, 70.4% indicating average treatment coverage of 71%. Conclusion: The identified strategies contributed to increased treatment coverage in experimental sites and should be applied in urban areas. Due to closeness of sites, spillover effects may have contributed to increased coverage in the control site.
引用
收藏
页数:9
相关论文
共 50 条
[31]   The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya [J].
Kusi, Caroline ;
Steinmann, Peter ;
Merten, Sonja .
INFECTIOUS DISEASES OF POVERTY, 2020, 9 (01)
[32]   Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration [J].
Cabral, Silvia ;
Bonfim, Cristine ;
Oliveira, Rosalira ;
Oliveira, Paula ;
Guimaraes, Terezinha ;
Brandao, Eduardo ;
Aguiar-Santos, Ana Maria ;
Medeiros, Zulma .
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2017, 59
[33]   Surveillance of lymphatic filariasis after stopping ten years of mass drug administration in rural communities in south India [J].
Ramaiah, K. D. ;
Vanamail, P. .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2013, 107 (05) :293-300
[34]   Post-Mass Drug Administration Transmission Assessment Survey for Elimination of Lymphatic Filariasis in La Cienaga, Dominican Republic [J].
Noland, Gregory S. ;
Blount, Stephen ;
Gonzalez, Manuel .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (06) :1292-1294
[35]   Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines [J].
Maria Lourdes E Amarillo ;
Vicente Y Belizario ;
Jewel T Sadiang-abay ;
Stephanie Anne M Sison ;
Ariane Marie S Dayag .
Parasites & Vectors, 1
[36]   Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review [J].
Babu, Bontha V. ;
Babu, Gopalan R. .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (09) :538-549
[37]   Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria [J].
Pam, Dung D. ;
de Souza, Dziedzom K. ;
D'Souza, Susan ;
Opoku, Millicent ;
Sanda, Safiya ;
Nazaradden, Ibrahim ;
Anagbogu, Ifeoma N. ;
Okoronkwo, Chukwu ;
Davies, Emmanuel ;
Elhassan, Elisabeth ;
Molyneux, David H. ;
Bockarie, Moses J. ;
Koudou, Benjamin G. .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (10)
[38]   Community and Drug Distributor Perceptions and Experiences of Mass Drug Administration for the Elimination of Lymphatic Filariasis: A Rapid Review of Qualitative Research [J].
Ames, Heather Melanie R. ;
Zuske, Meike ;
King, Jonathan D. ;
Steinmann, Peter ;
Bosch-Capblanch, Xavier .
HIGHLIGHTING OPERATIONAL AND IMPLEMENTATION RESEARCH FOR CONTROL OF HELMINTHIASIS, 2019, 103 :117-+
[39]   High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone [J].
Mary H Hodges ;
Samuel J Smith ;
Daniel Fussum ;
Joseph B Koroma ;
Abdul Conteh ;
Mustapha Sonnie ;
Santigie Sesay ;
Yaobi Zhang .
Parasites & Vectors, 3
[40]   High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone [J].
Hodges, Mary H. ;
Smith, Samuel J. ;
Fussum, Daniel ;
Koroma, Joseph B. ;
Conteh, Abdul ;
Sonnie, Mustapha ;
Sesay, Santigie ;
Zhang, Yaobi .
PARASITES & VECTORS, 2010, 3